Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors

Last updated: April 22, 2025
Sponsor: Mayo Clinic
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Prostate Cancer

Adenocarcinoma

Prostate Cancer, Early, Recurrent

Treatment

Focal laser ablation of the prostate

Clinical Study ID

NCT02600156
14-005500
  • Ages > 45
  • Male

Study Summary

The primary purpose of this study is to evaluate the feasibility and safety of MRI-guided focal laser ablation (Laser-Induced Interstitial Thermal Therapy, LITT) to treat low-risk native prostate cancer.

Eligibility Criteria

Inclusion

Inclusion Criteria

  • Male, 45 years of age or older.

  • Diagnosis of prostate adenocarcinoma.

  • Clinical stage T1c or T2a.

  • Gleason score of 7 (3+4 or 4+3) or Intermediate risk Gleason 6

  • PSA less than or equal to 20 ng/mL

  • Three or fewer biopsy locations with prostate cancer which correlate with MRI findings.

  • No lesion > or = 2cm

  • One, two, or three tumor suspicious regions identified on multiparametric MRI

  • No definite radiographic indication of extra-capsular extension.

  • Estimated survival of 5 years or greater, as determined by treating physician.

  • Tolerance for anesthesia/sedation.

  • Ability to give informed consent.

Exclusion Criteria

  • Presence of any condition (e.g., metal implant, shrapnel) not compatible with MRI.

  • History of other primary non-skin malignancy within previous three years.

Study Design

Total Participants: 7
Treatment Group(s): 1
Primary Treatment: Focal laser ablation of the prostate
Phase:
Study Start date:
September 01, 2015
Estimated Completion Date:
December 31, 2026

Study Description

The study is being done to evaluate the safety and effectiveness of Magnetic Resonance Imaging (MRI)-guided focal laser therapy with the Visualase Thermal Therapy System to treat low-risk prostate cancer tumors. Unlike surgery or radiotherapy which affects a large portion of the prostate or the entire organ, localized or focal therapy is intended to treat a small portion of tissue in which the cancer has been found by biopsy.

Connect with a study center

  • Mayo Clinic in Minnesota

    Rochester, Minnesota 55905
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.